FDA Approves New Treatment for Type 2 Diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults. Victoza is intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines. It is not recommended as initial therapy in patients who have not achieved adequate diabetes control [...]

Study Compares Diabetes’ Drugs

From Britain’s National Health System The Daily Mirror has reported that drugs used to control blood sugar in type 2 diabetes could increase risk of heart failure and death. It said that when taken alone one group of drugs, called the sulphonylureas, increased risk of death by 61% and of heart failure by 30% compared [...]